

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.02238019 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.02238019 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.45624030 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.45624030 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 5.36621778 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.15613013 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.89940010 |
| 8 | bile acid biosynthetic process (GO:0006699) | 4.60240969 |
| 9 | kynurenine metabolic process (GO:0070189) | 4.52981052 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 4.43488462 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 4.43488462 |
| 12 | tryptophan catabolic process (GO:0006569) | 4.43488462 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.40497916 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 4.35845790 |
| 15 | glyoxylate metabolic process (GO:0046487) | 4.29321949 |
| 16 | urea metabolic process (GO:0019627) | 4.25052837 |
| 17 | urea cycle (GO:0000050) | 4.25052837 |
| 18 | tryptophan metabolic process (GO:0006568) | 4.24161221 |
| 19 | complement activation, alternative pathway (GO:0006957) | 4.19296282 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.16823307 |
| 21 | cysteine metabolic process (GO:0006534) | 4.16303132 |
| 22 | regulation of fibrinolysis (GO:0051917) | 4.14832931 |
| 23 | regulation of triglyceride catabolic process (GO:0010896) | 4.14566242 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.13546761 |
| 25 | protein carboxylation (GO:0018214) | 4.13546761 |
| 26 | regulation of protein activation cascade (GO:2000257) | 4.04275375 |
| 27 | tyrosine metabolic process (GO:0006570) | 4.02813071 |
| 28 | cellular response to ethanol (GO:0071361) | 3.96392795 |
| 29 | bile acid metabolic process (GO:0008206) | 3.91751946 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 3.86194954 |
| 31 | interkinetic nuclear migration (GO:0022027) | 3.82832575 |
| 32 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.78969712 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 3.78506116 |
| 34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.76513676 |
| 35 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.74722042 |
| 36 | lysine metabolic process (GO:0006553) | 3.74544598 |
| 37 | lysine catabolic process (GO:0006554) | 3.74544598 |
| 38 | regulation of complement activation (GO:0030449) | 3.74471077 |
| 39 | valine metabolic process (GO:0006573) | 3.73762400 |
| 40 | triglyceride homeostasis (GO:0070328) | 3.72479721 |
| 41 | acylglycerol homeostasis (GO:0055090) | 3.72479721 |
| 42 | plasma lipoprotein particle clearance (GO:0034381) | 3.69100463 |
| 43 | regulation of cholesterol homeostasis (GO:2000188) | 3.68953053 |
| 44 | reverse cholesterol transport (GO:0043691) | 3.67295365 |
| 45 | glutamate metabolic process (GO:0006536) | 3.64967235 |
| 46 | macromolecular complex remodeling (GO:0034367) | 3.64965545 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 3.64965545 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 3.64965545 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 3.62706162 |
| 50 | negative regulation of sterol transport (GO:0032372) | 3.62706162 |
| 51 | aromatic amino acid family metabolic process (GO:0009072) | 3.57229809 |
| 52 | phospholipid efflux (GO:0033700) | 3.54622521 |
| 53 | positive regulation of lipid catabolic process (GO:0050996) | 3.51694629 |
| 54 | ethanol oxidation (GO:0006069) | 3.46305559 |
| 55 | cholesterol efflux (GO:0033344) | 3.42372078 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 3.40925278 |
| 57 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.40473818 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 3.39422137 |
| 59 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.39361853 |
| 60 | phospholipid homeostasis (GO:0055091) | 3.37912548 |
| 61 | plasma lipoprotein particle assembly (GO:0034377) | 3.34562496 |
| 62 | regulation of cholesterol esterification (GO:0010872) | 3.30800303 |
| 63 | short-chain fatty acid metabolic process (GO:0046459) | 3.30136383 |
| 64 | negative regulation of lipase activity (GO:0060192) | 3.30092164 |
| 65 | B cell receptor signaling pathway (GO:0050853) | 3.28684260 |
| 66 | alpha-amino acid catabolic process (GO:1901606) | 3.28309836 |
| 67 | regulation of gamma-delta T cell activation (GO:0046643) | 3.27992239 |
| 68 | cellular glucuronidation (GO:0052695) | 3.27072850 |
| 69 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.25795923 |
| 70 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.25795923 |
| 71 | protein-lipid complex assembly (GO:0065005) | 3.24430590 |
| 72 | homocysteine metabolic process (GO:0050667) | 3.20501699 |
| 73 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.16697395 |
| 74 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16697395 |
| 75 | 2-oxoglutarate metabolic process (GO:0006103) | 3.16276612 |
| 76 | regulation of relaxation of muscle (GO:1901077) | 3.13508158 |
| 77 | serine family amino acid catabolic process (GO:0009071) | 3.13368407 |
| 78 | fibrinolysis (GO:0042730) | 3.12617871 |
| 79 | ketone body metabolic process (GO:1902224) | 3.10706183 |
| 80 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.09886478 |
| 81 | acetyl-CoA metabolic process (GO:0006084) | 3.09266290 |
| 82 | cholesterol homeostasis (GO:0042632) | 3.06526037 |
| 83 | indolalkylamine metabolic process (GO:0006586) | 3.04749783 |
| 84 | drug catabolic process (GO:0042737) | 3.03781425 |
| 85 | sterol homeostasis (GO:0055092) | 3.03197549 |
| 86 | bile acid and bile salt transport (GO:0015721) | 3.02469599 |
| 87 | positive regulation of histone deacetylation (GO:0031065) | 3.01660626 |
| 88 | plasma lipoprotein particle organization (GO:0071827) | 2.98450027 |
| 89 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.98226913 |
| 90 | cellular amino acid catabolic process (GO:0009063) | 2.97953886 |
| 91 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.96705744 |
| 92 | regulation of germinal center formation (GO:0002634) | 2.96652404 |
| 93 | very long-chain fatty acid metabolic process (GO:0000038) | 2.96529036 |
| 94 | benzene-containing compound metabolic process (GO:0042537) | 2.96362934 |
| 95 | opsonization (GO:0008228) | 2.96108267 |
| 96 | cellular modified amino acid catabolic process (GO:0042219) | 2.95507639 |
| 97 | complement activation, classical pathway (GO:0006958) | 2.95363886 |
| 98 | coenzyme catabolic process (GO:0009109) | 2.95304556 |
| 99 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95103814 |
| 100 | protein-lipid complex subunit organization (GO:0071825) | 2.94896822 |
| 101 | fatty acid oxidation (GO:0019395) | 2.94346857 |
| 102 | cellular extravasation (GO:0045123) | 2.94283101 |
| 103 | low-density lipoprotein particle remodeling (GO:0034374) | 2.93509282 |
| 104 | V(D)J recombination (GO:0033151) | 2.93171163 |
| 105 | complement activation (GO:0006956) | 2.91830029 |
| 106 | regulation of triglyceride metabolic process (GO:0090207) | 2.91723162 |
| 107 | regulation of cholesterol metabolic process (GO:0090181) | 2.91452067 |
| 108 | creatine metabolic process (GO:0006600) | 2.90516310 |
| 109 | positive regulation of B cell differentiation (GO:0045579) | 2.89744572 |
| 110 | lipid oxidation (GO:0034440) | 2.89273278 |
| 111 | positive regulation of granulocyte differentiation (GO:0030854) | 2.86913506 |
| 112 | regulation of skeletal muscle contraction (GO:0014819) | 2.85667782 |
| 113 | muscle filament sliding (GO:0030049) | 2.83392457 |
| 114 | actin-myosin filament sliding (GO:0033275) | 2.83392457 |
| 115 | germinal center formation (GO:0002467) | 2.81799169 |
| 116 | Golgi to endosome transport (GO:0006895) | 2.78364608 |
| 117 | establishment of protein localization to Golgi (GO:0072600) | 2.77230210 |
| 118 | skeletal muscle contraction (GO:0003009) | 2.76404178 |
| 119 | positive thymic T cell selection (GO:0045059) | 2.75301276 |
| 120 | histone H3-K36 demethylation (GO:0070544) | 2.74382862 |
| 121 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.73917163 |
| 122 | positive T cell selection (GO:0043368) | 2.73177285 |
| 123 | positive regulation of Rap GTPase activity (GO:0032854) | 2.73107897 |
| 124 | definitive hemopoiesis (GO:0060216) | 2.72914648 |
| 125 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.69967858 |
| 126 | negative regulation of cell killing (GO:0031342) | 2.69967858 |
| 127 | protein targeting to Golgi (GO:0000042) | 2.69871796 |
| 128 | activated T cell proliferation (GO:0050798) | 2.69425276 |
| 129 | neuronal action potential propagation (GO:0019227) | 2.68972656 |
| 130 | regulation of ARF protein signal transduction (GO:0032012) | 2.66871764 |
| 131 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.66813407 |
| 132 | piRNA metabolic process (GO:0034587) | 2.56440794 |
| 133 | histone H3-K9 demethylation (GO:0033169) | 2.56381077 |
| 134 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.53771453 |
| 135 | nerve growth factor signaling pathway (GO:0038180) | 2.52054143 |
| 136 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.45165475 |
| 137 | regulation of granulocyte differentiation (GO:0030852) | 2.44047369 |
| 138 | myofibril assembly (GO:0030239) | 2.42133400 |
| 139 | histone lysine demethylation (GO:0070076) | 2.42127619 |
| 140 | growth hormone receptor signaling pathway (GO:0060396) | 2.41865441 |
| 141 | carnitine transmembrane transport (GO:1902603) | 2.41634381 |
| 142 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.41176532 |
| 143 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.39766890 |
| 144 | fatty acid transmembrane transport (GO:1902001) | 2.36572230 |
| 145 | histone demethylation (GO:0016577) | 2.36276798 |
| 146 | nucleus localization (GO:0051647) | 2.36112708 |
| 147 | regulation of Rap GTPase activity (GO:0032317) | 2.34240197 |
| 148 | macroautophagy (GO:0016236) | 2.31138667 |
| 149 | DNA methylation involved in gamete generation (GO:0043046) | 2.30758325 |
| 150 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.30365800 |
| 151 | carnitine shuttle (GO:0006853) | 2.29147368 |
| 152 | macrophage activation involved in immune response (GO:0002281) | 2.27814446 |
| 153 | actin-mediated cell contraction (GO:0070252) | 2.27653366 |
| 154 | regulation of beta-amyloid formation (GO:1902003) | 2.24430964 |
| 155 | histone H3-K4 trimethylation (GO:0080182) | 2.23711488 |
| 156 | response to muramyl dipeptide (GO:0032495) | 2.23452702 |
| 157 | cellular response to epinephrine stimulus (GO:0071872) | 2.23047327 |
| 158 | negative regulation of granulocyte differentiation (GO:0030853) | 2.22526628 |
| 159 | cellular response to growth hormone stimulus (GO:0071378) | 2.22213195 |
| 160 | regulation of energy homeostasis (GO:2000505) | 2.21823778 |
| 161 | carnitine transport (GO:0015879) | 2.21766822 |
| 162 | amino-acid betaine transport (GO:0015838) | 2.21766822 |
| 163 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.20601277 |
| 164 | striated muscle contraction (GO:0006941) | 2.17975312 |
| 165 | regulation of female gonad development (GO:2000194) | 2.15944184 |
| 166 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.15752914 |
| 167 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.15573758 |
| 168 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.15550027 |
| 169 | negative regulation of interleukin-17 production (GO:0032700) | 2.14841083 |
| 170 | lipid translocation (GO:0034204) | 2.14216605 |
| 171 | phospholipid translocation (GO:0045332) | 2.14216605 |
| 172 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.14176924 |
| 173 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.13622316 |
| 174 | negative regulation of T cell mediated immunity (GO:0002710) | 2.13309406 |
| 175 | neutrophil activation involved in immune response (GO:0002283) | 2.12300552 |
| 176 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.11713018 |
| 177 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.08443982 |
| 178 | B cell homeostasis (GO:0001782) | 2.07737950 |
| 179 | exogenous drug catabolic process (GO:0042738) | 2.07053228 |
| 180 | negative regulation of inclusion body assembly (GO:0090084) | 2.06590191 |
| 181 | cellular response to reactive nitrogen species (GO:1902170) | 2.06466338 |
| 182 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.06425061 |
| 183 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.05489452 |
| 184 | T cell selection (GO:0045058) | 2.04030625 |
| 185 | skeletal muscle adaptation (GO:0043501) | 2.03251216 |
| 186 | cardiac muscle hypertrophy (GO:0003300) | 2.03171804 |
| 187 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.02037484 |
| 188 | protein K11-linked deubiquitination (GO:0035871) | 2.01955277 |
| 189 | potassium ion import (GO:0010107) | 2.01414359 |
| 190 | response to epinephrine (GO:0071871) | 2.00707601 |
| 191 | protein K48-linked deubiquitination (GO:0071108) | 1.99843704 |
| 192 | negative regulation of B cell mediated immunity (GO:0002713) | 1.98388417 |
| 193 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 1.98388417 |
| 194 | vesicle transport along microtubule (GO:0047496) | 1.96821570 |
| 195 | protein demethylation (GO:0006482) | 1.96180952 |
| 196 | protein dealkylation (GO:0008214) | 1.96180952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.81260030 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.51622315 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.75409113 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.56397386 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.26320975 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.96079836 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.65941948 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.27675153 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.27379555 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.00188931 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.84574697 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.79010406 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.78063816 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.47845455 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.46181470 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.39739303 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.20380191 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.15810795 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.15625572 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04610768 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 1.91480735 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85651049 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.81315147 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79373912 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.75500408 |
| 26 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.72317111 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67769004 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.66302802 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.62779390 |
| 30 | GATA1_19941826_ChIP-Seq_K562_Human | 1.59923419 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.57977215 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55490426 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54567464 |
| 34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51171671 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49701996 |
| 36 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49227506 |
| 37 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.48702483 |
| 38 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47336598 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45844042 |
| 40 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45390725 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43523965 |
| 42 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43127854 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40331785 |
| 44 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40276009 |
| 45 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.39201692 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38434698 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.37754448 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.37672015 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36977860 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.36468038 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32539797 |
| 52 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32080147 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30172733 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.29581574 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28391704 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.25779378 |
| 57 | GATA2_19941826_ChIP-Seq_K562_Human | 1.23661151 |
| 58 | * GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23382620 |
| 59 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23299773 |
| 60 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22208457 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22167956 |
| 62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21518130 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20538613 |
| 64 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18186617 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17535394 |
| 66 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.16348923 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.14980917 |
| 68 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14759019 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14716604 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14378653 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12363505 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11938432 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11582156 |
| 74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10388262 |
| 75 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10369177 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09562086 |
| 77 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.08287255 |
| 78 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08171658 |
| 79 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07745827 |
| 80 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07745827 |
| 81 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06066251 |
| 82 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06011352 |
| 83 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.05631644 |
| 84 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05085253 |
| 85 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.00905712 |
| 86 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00234025 |
| 87 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00234025 |
| 88 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99986071 |
| 89 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99663578 |
| 90 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99333529 |
| 91 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.98738933 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98565246 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97046999 |
| 94 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96493013 |
| 95 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.96092553 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95919274 |
| 97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94947962 |
| 98 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.94320619 |
| 99 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94208617 |
| 100 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93834871 |
| 101 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93547673 |
| 102 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93477589 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93461451 |
| 104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93335806 |
| 105 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93154048 |
| 106 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92434917 |
| 107 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.92422020 |
| 108 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91895194 |
| 109 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91276828 |
| 110 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90813485 |
| 111 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.90413452 |
| 112 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89788676 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89785204 |
| 114 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89709108 |
| 115 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89536743 |
| 116 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89436134 |
| 117 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.89212356 |
| 118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88805076 |
| 119 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88507913 |
| 120 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88228956 |
| 121 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87864677 |
| 122 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87376274 |
| 123 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87315336 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86866489 |
| 125 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85716630 |
| 126 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85629292 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85151317 |
| 128 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84969787 |
| 129 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.84644103 |
| 130 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84372848 |
| 131 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84228456 |
| 132 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.83440204 |
| 133 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83187554 |
| 134 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82855531 |
| 135 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81666081 |
| 136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81455679 |
| 137 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.80539489 |
| 138 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.77170268 |
| 139 | SPI1_23127762_ChIP-Seq_K562_Human | 0.76971456 |
| 140 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76162229 |
| 141 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.76109762 |
| 142 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.74828906 |
| 143 | GATA3_26560356_Chip-Seq_TH1_Human | 0.74791525 |
| 144 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.74434822 |
| 145 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.73893324 |
| 146 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.73893324 |
| 147 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73821100 |
| 148 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.73807329 |
| 149 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73528652 |
| 150 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.73003711 |
| 151 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.72446489 |
| 152 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.71419724 |
| 153 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.71052043 |
| 154 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.70732552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.45531121 |
| 2 | MP0005360_urolithiasis | 5.65596680 |
| 3 | MP0005365_abnormal_bile_salt | 4.80496189 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.53870604 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.87933385 |
| 6 | MP0003646_muscle_fatigue | 3.12931522 |
| 7 | MP0003252_abnormal_bile_duct | 3.10843165 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.04306481 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.85990870 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 2.63851237 |
| 11 | MP0009840_abnormal_foam_cell | 2.52988336 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.29841312 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.22078155 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.21641346 |
| 15 | MP0005083_abnormal_biliary_tract | 2.21450369 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.15989133 |
| 17 | MP0000609_abnormal_liver_physiology | 2.14840666 |
| 18 | MP0003656_abnormal_erythrocyte_physiolo | 2.14138841 |
| 19 | MP0002009_preneoplasia | 1.96848496 |
| 20 | MP0003183_abnormal_peptide_metabolism | 1.95952658 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.95537024 |
| 22 | MP0003868_abnormal_feces_composition | 1.92350568 |
| 23 | MP0004130_abnormal_muscle_cell | 1.89951763 |
| 24 | MP0005332_abnormal_amino_acid | 1.84473913 |
| 25 | MP0000685_abnormal_immune_system | 1.81047972 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.78057038 |
| 27 | MP0008877_abnormal_DNA_methylation | 1.76395311 |
| 28 | MP0004084_abnormal_cardiac_muscle | 1.67629207 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.64123745 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62564868 |
| 31 | MP0003195_calcinosis | 1.62350236 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.60829552 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.49546333 |
| 34 | MP0003011_delayed_dark_adaptation | 1.47951436 |
| 35 | MP0001501_abnormal_sleep_pattern | 1.45350443 |
| 36 | MP0004947_skin_inflammation | 1.39637427 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.38746702 |
| 38 | MP0002106_abnormal_muscle_physiology | 1.37390674 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.37317267 |
| 40 | MP0004484_altered_response_of | 1.36713837 |
| 41 | MP0001800_abnormal_humoral_immune | 1.34978359 |
| 42 | MP0003828_pulmonary_edema | 1.30084986 |
| 43 | MP0003436_decreased_susceptibility_to | 1.29664546 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.26478147 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.24243298 |
| 46 | MP0003303_peritoneal_inflammation | 1.24211780 |
| 47 | MP0000604_amyloidosis | 1.23754502 |
| 48 | MP0001790_abnormal_immune_system | 1.23292957 |
| 49 | MP0005387_immune_system_phenotype | 1.23292957 |
| 50 | MP0008057_abnormal_DNA_replication | 1.21756549 |
| 51 | MP0003787_abnormal_imprinting | 1.19933380 |
| 52 | MP0003690_abnormal_glial_cell | 1.18856055 |
| 53 | MP0003879_abnormal_hair_cell | 1.18016878 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 1.17440005 |
| 55 | MP0009764_decreased_sensitivity_to | 1.17025234 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.13333872 |
| 57 | MP0000749_muscle_degeneration | 1.12464095 |
| 58 | MP0004510_myositis | 1.12331161 |
| 59 | MP0004859_abnormal_synaptic_plasticity | 1.12325736 |
| 60 | MP0003045_fibrosis | 1.10398650 |
| 61 | MP0000598_abnormal_liver_morphology | 1.09832106 |
| 62 | MP0002971_abnormal_brown_adipose | 1.07928007 |
| 63 | MP0005671_abnormal_response_to | 1.06153738 |
| 64 | MP0004270_analgesia | 1.05983829 |
| 65 | MP0008004_abnormal_stomach_pH | 1.05854383 |
| 66 | MP0002006_tumorigenesis | 1.05789412 |
| 67 | MP0005666_abnormal_adipose_tissue | 1.05752138 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 1.05690463 |
| 69 | MP0004043_abnormal_pH_regulation | 1.03438490 |
| 70 | MP0009785_altered_susceptibility_to | 1.03182274 |
| 71 | MP0009763_increased_sensitivity_to | 1.02830538 |
| 72 | MP0001835_abnormal_antigen_presentation | 1.01653039 |
| 73 | MP0000920_abnormal_myelination | 1.00797959 |
| 74 | MP0002064_seizures | 1.00710860 |
| 75 | MP0000747_muscle_weakness | 1.00652895 |
| 76 | MP0001486_abnormal_startle_reflex | 1.00086325 |
| 77 | MP0004087_abnormal_muscle_fiber | 0.99550826 |
| 78 | MP0009643_abnormal_urine_homeostasis | 0.99471192 |
| 79 | MP0005369_muscle_phenotype | 0.99407969 |
| 80 | MP0010234_abnormal_vibrissa_follicle | 0.99308064 |
| 81 | MP0003635_abnormal_synaptic_transmissio | 0.98105305 |
| 82 | MP0002398_abnormal_bone_marrow | 0.97506516 |
| 83 | MP0004019_abnormal_vitamin_homeostasis | 0.97369185 |
| 84 | MP0005334_abnormal_fat_pad | 0.96391356 |
| 85 | MP0008469_abnormal_protein_level | 0.95804600 |
| 86 | MP0005423_abnormal_somatic_nervous | 0.95794355 |
| 87 | MP0001661_extended_life_span | 0.95445555 |
| 88 | MP0010155_abnormal_intestine_physiology | 0.95201654 |
| 89 | MP0000759_abnormal_skeletal_muscle | 0.94912342 |
| 90 | MP0002405_respiratory_system_inflammati | 0.94682174 |
| 91 | MP0002723_abnormal_immune_serum | 0.93543732 |
| 92 | MP0000569_abnormal_digit_pigmentation | 0.92079208 |
| 93 | MP0005620_abnormal_muscle_contractility | 0.91893205 |
| 94 | MP0000689_abnormal_spleen_morphology | 0.91890927 |
| 95 | MP0008995_early_reproductive_senescence | 0.91224244 |
| 96 | MP0005266_abnormal_metabolism | 0.90118333 |
| 97 | MP0003633_abnormal_nervous_system | 0.89714953 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.89170758 |
| 99 | MP0002063_abnormal_learning/memory/cond | 0.87301814 |
| 100 | MP0009115_abnormal_fat_cell | 0.87196619 |
| 101 | MP0001765_abnormal_ion_homeostasis | 0.87174802 |
| 102 | MP0002132_abnormal_respiratory_system | 0.87142481 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.86780457 |
| 104 | MP0002452_abnormal_antigen_presenting | 0.86776173 |
| 105 | MP0001764_abnormal_homeostasis | 0.86514582 |
| 106 | MP0000716_abnormal_immune_system | 0.85676536 |
| 107 | MP0002272_abnormal_nervous_system | 0.85225515 |
| 108 | MP0003329_amyloid_beta_deposits | 0.85218088 |
| 109 | MP0004924_abnormal_behavior | 0.85108749 |
| 110 | MP0005386_behavior/neurological_phenoty | 0.85108749 |
| 111 | MP0002127_abnormal_cardiovascular_syste | 0.84866918 |
| 112 | MP0000703_abnormal_thymus_morphology | 0.84856023 |
| 113 | MP0009745_abnormal_behavioral_response | 0.83886260 |
| 114 | MP0006054_spinal_hemorrhage | 0.83616879 |
| 115 | MP0005025_abnormal_response_to | 0.83551361 |
| 116 | MP0001851_eye_inflammation | 0.83051612 |
| 117 | MP0008569_lethality_at_weaning | 0.83038778 |
| 118 | MP0004215_abnormal_myocardial_fiber | 0.82978700 |
| 119 | MP0005000_abnormal_immune_tolerance | 0.82589144 |
| 120 | MP0009278_abnormal_bone_marrow | 0.82383619 |
| 121 | MP0002269_muscular_atrophy | 0.81509982 |
| 122 | MP0003724_increased_susceptibility_to | 0.81491392 |
| 123 | MP0002722_abnormal_immune_system | 0.81276408 |
| 124 | MP0002420_abnormal_adaptive_immunity | 0.80649904 |
| 125 | MP0001845_abnormal_inflammatory_respons | 0.80072240 |
| 126 | MP0005408_hypopigmentation | 0.79043318 |
| 127 | MP0001879_abnormal_lymphatic_vessel | 0.78375073 |
| 128 | MP0001819_abnormal_immune_cell | 0.77990856 |
| 129 | MP0002419_abnormal_innate_immunity | 0.77577482 |
| 130 | MP0005451_abnormal_body_composition | 0.76438200 |
| 131 | MP0003075_altered_response_to | 0.76011164 |
| 132 | MP0000465_gastrointestinal_hemorrhage | 0.74699467 |
| 133 | MP0005397_hematopoietic_system_phenotyp | 0.74080977 |
| 134 | MP0001545_abnormal_hematopoietic_system | 0.74080977 |
| 135 | MP0005220_abnormal_exocrine_pancreas | 0.73063470 |
| 136 | MP0009642_abnormal_blood_homeostasis | 0.72987160 |
| 137 | MP0002933_joint_inflammation | 0.72933766 |
| 138 | MP0002877_abnormal_melanocyte_morpholog | 0.71715828 |
| 139 | MP0004381_abnormal_hair_follicle | 0.70631390 |
| 140 | MP0008874_decreased_physiological_sensi | 0.70494928 |
| 141 | MP0003453_abnormal_keratinocyte_physiol | 0.69617616 |
| 142 | MP0006082_CNS_inflammation | 0.68679387 |
| 143 | MP0005375_adipose_tissue_phenotype | 0.67465512 |
| 144 | MP0001853_heart_inflammation | 0.67298298 |
| 145 | MP0010368_abnormal_lymphatic_system | 0.66999130 |
| 146 | MP0005551_abnormal_eye_electrophysiolog | 0.66860679 |
| 147 | MP0005636_abnormal_mineral_homeostasis | 0.66828123 |
| 148 | MP0002429_abnormal_blood_cell | 0.66660366 |
| 149 | MP0005535_abnormal_body_temperature | 0.65345953 |
| 150 | MP0008961_abnormal_basal_metabolism | 0.64741964 |
| 151 | MP0002876_abnormal_thyroid_physiology | 0.63120323 |
| 152 | MP0010678_abnormal_skin_adnexa | 0.62854723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.23952521 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 5.30385986 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.27848536 |
| 4 | Nemaline bodies (HP:0003798) | 5.13193664 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.06214837 |
| 6 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.96007987 |
| 7 | Exercise-induced myalgia (HP:0003738) | 4.86188632 |
| 8 | Xanthomatosis (HP:0000991) | 4.75748919 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.66068939 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.62614532 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 4.51625087 |
| 12 | Hypoplasia of the thymus (HP:0000778) | 4.25290953 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.22462743 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 3.88904974 |
| 15 | Complement deficiency (HP:0004431) | 3.83455429 |
| 16 | B lymphocytopenia (HP:0010976) | 3.76475727 |
| 17 | Abnormality of B cell number (HP:0010975) | 3.76475727 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.74553096 |
| 19 | Subaortic stenosis (HP:0001682) | 3.74553096 |
| 20 | T lymphocytopenia (HP:0005403) | 3.72600175 |
| 21 | Thyroiditis (HP:0100646) | 3.72213719 |
| 22 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.64117424 |
| 23 | Joint hemorrhage (HP:0005261) | 3.55399456 |
| 24 | Abnormality of T cell number (HP:0011839) | 3.48496666 |
| 25 | Hypolipoproteinemia (HP:0010981) | 3.41282286 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.35756364 |
| 27 | Epidermoid cyst (HP:0200040) | 3.34513420 |
| 28 | Ketosis (HP:0001946) | 3.26524505 |
| 29 | Acanthocytosis (HP:0001927) | 3.26420697 |
| 30 | Severe combined immunodeficiency (HP:0004430) | 3.22016700 |
| 31 | Distal arthrogryposis (HP:0005684) | 3.19009733 |
| 32 | Panhypogammaglobulinemia (HP:0003139) | 3.16436456 |
| 33 | Muscle fiber splitting (HP:0003555) | 3.10757294 |
| 34 | Hyperammonemia (HP:0001987) | 3.07283379 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.05130865 |
| 36 | Combined immunodeficiency (HP:0005387) | 3.02249643 |
| 37 | Recurrent viral infections (HP:0004429) | 3.02214800 |
| 38 | Papilloma (HP:0012740) | 3.00582355 |
| 39 | Verrucae (HP:0200043) | 3.00582355 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.98211681 |
| 41 | Type 1 muscle fiber predominance (HP:0003803) | 2.98164842 |
| 42 | Hyporeflexia of lower limbs (HP:0002600) | 2.96925165 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.91952989 |
| 44 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.90510481 |
| 45 | Mitral stenosis (HP:0001718) | 2.89367984 |
| 46 | Bundle branch block (HP:0011710) | 2.88544890 |
| 47 | EMG: myopathic abnormalities (HP:0003458) | 2.85738222 |
| 48 | Febrile seizures (HP:0002373) | 2.84130470 |
| 49 | Hyperkalemia (HP:0002153) | 2.79556443 |
| 50 | Difficulty running (HP:0009046) | 2.78385185 |
| 51 | Calf muscle hypertrophy (HP:0008981) | 2.77476952 |
| 52 | Fat malabsorption (HP:0002630) | 2.75886868 |
| 53 | Myocardial infarction (HP:0001658) | 2.72445470 |
| 54 | Hyperventilation (HP:0002883) | 2.70767269 |
| 55 | Hypoglycemic coma (HP:0001325) | 2.70039749 |
| 56 | Frequent falls (HP:0002359) | 2.65916903 |
| 57 | Agammaglobulinemia (HP:0004432) | 2.64989919 |
| 58 | Abnormality of methionine metabolism (HP:0010901) | 2.59440797 |
| 59 | Exercise-induced muscle cramps (HP:0003710) | 2.58702169 |
| 60 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.57434960 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.57393010 |
| 62 | Hypochromic microcytic anemia (HP:0004840) | 2.57338951 |
| 63 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56394685 |
| 64 | Fair hair (HP:0002286) | 2.55741497 |
| 65 | Papilledema (HP:0001085) | 2.54678524 |
| 66 | Abnormality of complement system (HP:0005339) | 2.52944602 |
| 67 | Abnormality of the intrinsic pathway (HP:0010989) | 2.52748880 |
| 68 | Poikilocytosis (HP:0004447) | 2.49321626 |
| 69 | Ventricular fibrillation (HP:0001663) | 2.48771372 |
| 70 | Rhabdomyolysis (HP:0003201) | 2.46534147 |
| 71 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.45968448 |
| 72 | Abnormality of glycine metabolism (HP:0010895) | 2.45968448 |
| 73 | Hepatocellular carcinoma (HP:0001402) | 2.44752759 |
| 74 | Rimmed vacuoles (HP:0003805) | 2.42233435 |
| 75 | Gingival bleeding (HP:0000225) | 2.39811096 |
| 76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.38609332 |
| 77 | Conjugated hyperbilirubinemia (HP:0002908) | 2.35141578 |
| 78 | Myopathic facies (HP:0002058) | 2.31994850 |
| 79 | Truncal obesity (HP:0001956) | 2.28654001 |
| 80 | Hyperglycinemia (HP:0002154) | 2.28545454 |
| 81 | Myoglobinuria (HP:0002913) | 2.27625737 |
| 82 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.26458791 |
| 83 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.26458791 |
| 84 | Ketoacidosis (HP:0001993) | 2.25037105 |
| 85 | Spastic diplegia (HP:0001264) | 2.24949403 |
| 86 | Hemorrhage of the eye (HP:0011885) | 2.24934315 |
| 87 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.23090569 |
| 88 | Postural instability (HP:0002172) | 2.22442520 |
| 89 | Eczematoid dermatitis (HP:0000976) | 2.21580058 |
| 90 | Papillary thyroid carcinoma (HP:0002895) | 2.21482068 |
| 91 | Pigmentary retinal degeneration (HP:0001146) | 2.17066142 |
| 92 | Spontaneous abortion (HP:0005268) | 2.16090916 |
| 93 | Cellulitis (HP:0100658) | 2.14985777 |
| 94 | Small epiphyses (HP:0010585) | 2.14443167 |
| 95 | Eosinophilia (HP:0001880) | 2.13151712 |
| 96 | Colitis (HP:0002583) | 2.13004753 |
| 97 | EMG: neuropathic changes (HP:0003445) | 2.12219434 |
| 98 | Abnormality of the periventricular white matter (HP:0002518) | 2.11687439 |
| 99 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.11215432 |
| 100 | Prolonged bleeding time (HP:0003010) | 2.11187574 |
| 101 | Generalized hypopigmentation of hair (HP:0011358) | 2.10352854 |
| 102 | Hyperglycinuria (HP:0003108) | 2.09731680 |
| 103 | Abnormal tarsal ossification (HP:0008369) | 2.09434536 |
| 104 | Focal motor seizures (HP:0011153) | 2.08412274 |
| 105 | Ulnar deviation of the wrist (HP:0003049) | 2.08044525 |
| 106 | Pulmonary embolism (HP:0002204) | 2.02924513 |
| 107 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.01224946 |
| 108 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.00365095 |
| 109 | Abnormal gallbladder morphology (HP:0012437) | 1.98498987 |
| 110 | Abnormality of T cells (HP:0002843) | 1.97850954 |
| 111 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.97327808 |
| 112 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.97327808 |
| 113 | Heart block (HP:0012722) | 1.97277678 |
| 114 | Steatorrhea (HP:0002570) | 1.97191206 |
| 115 | Ankle clonus (HP:0011448) | 1.96293735 |
| 116 | Cholelithiasis (HP:0001081) | 1.95559206 |
| 117 | Abnormality of purine metabolism (HP:0004352) | 1.95442905 |
| 118 | Thrombophlebitis (HP:0004418) | 1.94481571 |
| 119 | Esophageal varix (HP:0002040) | 1.94022837 |
| 120 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93634233 |
| 121 | Genetic anticipation (HP:0003743) | 1.93581665 |
| 122 | Widely spaced teeth (HP:0000687) | 1.93009365 |
| 123 | Hypoproteinemia (HP:0003075) | 1.91199866 |
| 124 | Progressive cerebellar ataxia (HP:0002073) | 1.91149700 |
| 125 | Skin nodule (HP:0200036) | 1.89122010 |
| 126 | Sudden death (HP:0001699) | 1.87552861 |
| 127 | Dysmetric saccades (HP:0000641) | 1.86992146 |
| 128 | Recurrent fungal infections (HP:0002841) | 1.86528262 |
| 129 | Macroorchidism (HP:0000053) | 1.86315482 |
| 130 | Abnormal foot bone ossification (HP:0010675) | 1.86237448 |
| 131 | Epistaxis (HP:0000421) | 1.85919642 |
| 132 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.85554469 |
| 133 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85447249 |
| 134 | Round ear (HP:0100830) | 1.84988757 |
| 135 | Muscle stiffness (HP:0003552) | 1.84788228 |
| 136 | Stomach cancer (HP:0012126) | 1.84665398 |
| 137 | Vascular calcification (HP:0004934) | 1.84161580 |
| 138 | Protruding tongue (HP:0010808) | 1.83859123 |
| 139 | Spontaneous hematomas (HP:0007420) | 1.83339448 |
| 140 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.81771406 |
| 141 | Recurrent cutaneous fungal infections (HP:0011370) | 1.81771406 |
| 142 | Fetal akinesia sequence (HP:0001989) | 1.81670081 |
| 143 | Meningitis (HP:0001287) | 1.81515843 |
| 144 | Menorrhagia (HP:0000132) | 1.81106387 |
| 145 | Abnormality of potassium homeostasis (HP:0011042) | 1.79794224 |
| 146 | Sensorimotor neuropathy (HP:0007141) | 1.79435195 |
| 147 | Abnormality of nucleobase metabolism (HP:0010932) | 1.79009255 |
| 148 | Autoimmune thrombocytopenia (HP:0001973) | 1.78597936 |
| 149 | Acute myeloid leukemia (HP:0004808) | 1.78365833 |
| 150 | Delayed CNS myelination (HP:0002188) | 1.78094549 |
| 151 | Abnormal platelet volume (HP:0011876) | 1.77812743 |
| 152 | Abnormality of eosinophils (HP:0001879) | 1.77599259 |
| 153 | Recurrent abscess formation (HP:0002722) | 1.77436420 |
| 154 | Metabolic acidosis (HP:0001942) | 1.77336837 |
| 155 | Abnormality of the renal cortex (HP:0011035) | 1.75933425 |
| 156 | Reticulocytosis (HP:0001923) | 1.74668268 |
| 157 | Increased mean platelet volume (HP:0011877) | 1.74117028 |
| 158 | Abnormality of the fingertips (HP:0001211) | 1.73175726 |
| 159 | Abnormality of the calf musculature (HP:0001430) | 1.73119941 |
| 160 | Clumsiness (HP:0002312) | 1.71959562 |
| 161 | Increased circulating renin level (HP:0000848) | 1.71823396 |
| 162 | Hypoglycemic seizures (HP:0002173) | 1.71278681 |
| 163 | Recurrent bacterial skin infections (HP:0005406) | 1.71265387 |
| 164 | Abnormality of binocular vision (HP:0011514) | 1.71221570 |
| 165 | Diplopia (HP:0000651) | 1.71221570 |
| 166 | Hepatitis (HP:0012115) | 1.70332815 |
| 167 | Amyloidosis (HP:0011034) | 1.70306277 |
| 168 | Hematochezia (HP:0002573) | 1.70199387 |
| 169 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.69932663 |
| 170 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.69448948 |
| 171 | Blue irides (HP:0000635) | 1.68958939 |
| 172 | Polycythemia (HP:0001901) | 1.68744700 |
| 173 | Visual hallucinations (HP:0002367) | 1.68384425 |
| 174 | Granulocytopenia (HP:0001913) | 1.68329234 |
| 175 | Gastrointestinal infarctions (HP:0005244) | 1.66602276 |
| 176 | Optic neuritis (HP:0100653) | 1.65853308 |
| 177 | Retrobulbar optic neuritis (HP:0100654) | 1.65853308 |
| 178 | Polydipsia (HP:0001959) | 1.64822982 |
| 179 | Abnormal drinking behavior (HP:0030082) | 1.64822982 |
| 180 | Abnormality of the corticospinal tract (HP:0002492) | 1.64638767 |
| 181 | Stomatitis (HP:0010280) | 1.64024506 |
| 182 | Myositis (HP:0100614) | 1.63554795 |
| 183 | Chest pain (HP:0100749) | 1.63225258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 4.85282066 |
| 2 | OBSCN | 3.75296354 |
| 3 | TRIB3 | 2.96762693 |
| 4 | PKN2 | 2.95661901 |
| 5 | SIK1 | 2.82535636 |
| 6 | FGFR2 | 2.76213520 |
| 7 | ERN1 | 2.68091025 |
| 8 | FGFR4 | 2.65055035 |
| 9 | EEF2K | 2.52379226 |
| 10 | MAP4K1 | 2.51205033 |
| 11 | GRK6 | 2.23471968 |
| 12 | PHKG1 | 2.06099447 |
| 13 | PHKG2 | 2.06099447 |
| 14 | MAP3K7 | 2.03937088 |
| 15 | PRPF4B | 1.90231613 |
| 16 | EPHB1 | 1.78501327 |
| 17 | TAOK3 | 1.77660955 |
| 18 | ITK | 1.68322119 |
| 19 | PINK1 | 1.60516878 |
| 20 | CAMKK2 | 1.56787042 |
| 21 | PTK6 | 1.53893679 |
| 22 | DAPK2 | 1.50979263 |
| 23 | FGFR3 | 1.48721596 |
| 24 | BCKDK | 1.42717487 |
| 25 | FLT3 | 1.42531871 |
| 26 | TYK2 | 1.39291463 |
| 27 | MAPK12 | 1.35560292 |
| 28 | CAMK1G | 1.35094853 |
| 29 | STK10 | 1.32853280 |
| 30 | SGK494 | 1.27173125 |
| 31 | SGK223 | 1.27173125 |
| 32 | JAK1 | 1.26989200 |
| 33 | CAMK1D | 1.26217082 |
| 34 | MAP2K3 | 1.25874369 |
| 35 | MAPK11 | 1.21224560 |
| 36 | CDK6 | 1.20992344 |
| 37 | NTRK3 | 1.19833516 |
| 38 | RET | 1.19686244 |
| 39 | CSK | 1.19137151 |
| 40 | FRK | 1.19031435 |
| 41 | LRRK2 | 1.18841786 |
| 42 | JAK2 | 1.18341177 |
| 43 | SYK | 1.15219339 |
| 44 | CSF1R | 1.14809590 |
| 45 | PRKCH | 1.10949301 |
| 46 | BLK | 1.09878385 |
| 47 | TBK1 | 1.05011711 |
| 48 | PRKCQ | 1.03012950 |
| 49 | PIK3CG | 1.02585793 |
| 50 | SIK2 | 1.02567275 |
| 51 | CDK9 | 1.01856945 |
| 52 | PDGFRB | 1.01269817 |
| 53 | FES | 1.00645850 |
| 54 | RIPK4 | 1.00027141 |
| 55 | BMPR2 | 0.99889214 |
| 56 | MAPK4 | 0.99003312 |
| 57 | TNK2 | 0.98664338 |
| 58 | BTK | 0.97988561 |
| 59 | MAPK7 | 0.97441851 |
| 60 | SGK1 | 0.94046333 |
| 61 | IRAK1 | 0.94032513 |
| 62 | JAK3 | 0.93779125 |
| 63 | SGK3 | 0.93644315 |
| 64 | ZAP70 | 0.92756954 |
| 65 | HCK | 0.91968701 |
| 66 | INSRR | 0.90332482 |
| 67 | STK11 | 0.90089626 |
| 68 | PDK1 | 0.89355883 |
| 69 | RIPK1 | 0.87088539 |
| 70 | TGFBR2 | 0.86436243 |
| 71 | CAMK4 | 0.85564428 |
| 72 | MST1R | 0.83236800 |
| 73 | MAP3K3 | 0.82499448 |
| 74 | AKT3 | 0.82386823 |
| 75 | MAPK13 | 0.82053251 |
| 76 | HIPK2 | 0.81916930 |
| 77 | MAP2K4 | 0.80601390 |
| 78 | PRKAA2 | 0.79526383 |
| 79 | LCK | 0.78707862 |
| 80 | MAP3K2 | 0.78543201 |
| 81 | STK4 | 0.78308510 |
| 82 | CDK4 | 0.78188312 |
| 83 | MARK2 | 0.77270473 |
| 84 | IRAK4 | 0.76396505 |
| 85 | MAP3K14 | 0.74720417 |
| 86 | CDK19 | 0.74034232 |
| 87 | MAP3K1 | 0.73479083 |
| 88 | MAP3K6 | 0.70261408 |
| 89 | PRKD1 | 0.69698727 |
| 90 | NLK | 0.68610746 |
| 91 | TXK | 0.67972193 |
| 92 | PDPK1 | 0.67647829 |
| 93 | MAPK15 | 0.66419807 |
| 94 | IKBKE | 0.66110617 |
| 95 | EPHA3 | 0.66089133 |
| 96 | CAMK1 | 0.64445014 |
| 97 | MARK1 | 0.64343026 |
| 98 | YES1 | 0.62419893 |
| 99 | CDK12 | 0.62235448 |
| 100 | DYRK1A | 0.61755768 |
| 101 | TYRO3 | 0.61017902 |
| 102 | DYRK1B | 0.60995538 |
| 103 | UHMK1 | 0.60568436 |
| 104 | IRAK2 | 0.59812469 |
| 105 | MAP2K2 | 0.57836661 |
| 106 | TEC | 0.56967812 |
| 107 | TAOK1 | 0.56763574 |
| 108 | BMX | 0.56588573 |
| 109 | MAP3K13 | 0.55746086 |
| 110 | PRKAA1 | 0.54824781 |
| 111 | CDK3 | 0.54258984 |
| 112 | NEK6 | 0.53251883 |
| 113 | STK38 | 0.52947319 |
| 114 | PKN1 | 0.52899800 |
| 115 | MELK | 0.51642464 |
| 116 | MAP3K4 | 0.51545678 |
| 117 | FYN | 0.50456250 |
| 118 | CSNK1A1L | 0.50184184 |
| 119 | TRPM7 | 0.49860242 |
| 120 | NEK9 | 0.49503706 |
| 121 | WNK1 | 0.48549590 |
| 122 | LYN | 0.48230272 |
| 123 | PRKG1 | 0.47548731 |
| 124 | ICK | 0.46556122 |
| 125 | PIK3CA | 0.46442898 |
| 126 | CSNK1D | 0.45448584 |
| 127 | KIT | 0.45409256 |
| 128 | STK39 | 0.45171668 |
| 129 | CSNK1G1 | 0.44766721 |
| 130 | EGFR | 0.44399542 |
| 131 | RPS6KB2 | 0.43972055 |
| 132 | KSR2 | 0.42680951 |
| 133 | CAMKK1 | 0.41487329 |
| 134 | LATS1 | 0.41335735 |
| 135 | CSNK1G2 | 0.39705551 |
| 136 | TTN | 0.37898143 |
| 137 | INSR | 0.36903863 |
| 138 | STK3 | 0.36272129 |
| 139 | BRD4 | 0.36107981 |
| 140 | SGK2 | 0.34124967 |
| 141 | CLK1 | 0.33709544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.34120761 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.17689575 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.98167049 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.76018953 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.68635076 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53257515 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.50580505 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31425052 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.24996167 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.08164378 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.03251338 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95540348 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.93025089 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.87598305 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79465608 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.78666153 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.78202053 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.77954715 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76647565 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.73367485 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.68532313 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.65938954 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.64336027 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60517561 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.55797448 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.55202290 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.54048590 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.45783933 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41557637 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40171072 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.37098483 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36880347 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35869342 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34308835 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.34167489 |
| 36 | Long-term potentiation_Homo sapiens_hsa04720 | 1.28316143 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.27396253 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.27153738 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.19947020 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12273793 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11264113 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.09668678 |
| 43 | Asthma_Homo sapiens_hsa05310 | 1.09595408 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.09514867 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.09303382 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 1.08092086 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.07737486 |
| 48 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.07266676 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06599703 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04462348 |
| 51 | Renin secretion_Homo sapiens_hsa04924 | 1.02966425 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02246132 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 1.02015197 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01596051 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.01513187 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00711392 |
| 57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00391031 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.00245150 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98970032 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.97540093 |
| 61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97261305 |
| 62 | Circadian entrainment_Homo sapiens_hsa04713 | 0.97156683 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.96891560 |
| 64 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.96592435 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96240417 |
| 66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95800713 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.95162602 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94746215 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93952531 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93918079 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.93728038 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92398189 |
| 73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91257679 |
| 74 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.91219209 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.90448777 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.89245974 |
| 77 | Long-term depression_Homo sapiens_hsa04730 | 0.88463676 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88182716 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86475810 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.86189991 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86083408 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85680339 |
| 83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80243772 |
| 84 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79872922 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79335142 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78158825 |
| 87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77437040 |
| 88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77151987 |
| 89 | Morphine addiction_Homo sapiens_hsa05032 | 0.77118344 |
| 90 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.76847051 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74812058 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72137213 |
| 93 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71104534 |
| 94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70720856 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70698900 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70680194 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.69188868 |
| 98 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67832674 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67529595 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67486967 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67296566 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.67268268 |
| 103 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66889615 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66777257 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.65799260 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65498368 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65493950 |
| 108 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.65198363 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64545600 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63528727 |
| 111 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.63421727 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63040197 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62209380 |
| 114 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61598294 |
| 115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.60201621 |
| 116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59258955 |
| 117 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.59136225 |
| 118 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58626324 |
| 119 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58403147 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54750220 |
| 121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52704709 |
| 122 | Phototransduction_Homo sapiens_hsa04744 | 0.51705843 |
| 123 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47130972 |
| 124 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46219345 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45880638 |
| 126 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45737154 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44875095 |
| 128 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44460657 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43390874 |
| 130 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41639932 |
| 131 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40668967 |
| 132 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40299727 |
| 133 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39902924 |
| 134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39168861 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38330207 |
| 136 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36229760 |
| 137 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35974403 |
| 138 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35881142 |
| 139 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35120481 |
| 140 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34977271 |
| 141 | Platelet activation_Homo sapiens_hsa04611 | 0.32098066 |
| 142 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29326007 |
| 143 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28684282 |
| 144 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27347719 |
| 145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26044325 |
| 146 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.25729212 |
| 147 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.25351675 |
| 148 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22841917 |
| 149 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22160046 |
| 150 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.22038884 |
| 151 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.21904403 |
| 152 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21628922 |
| 153 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21399598 |
| 154 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.21021565 |
| 155 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.20257193 |
| 156 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.19102339 |
| 157 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17758411 |
| 158 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.16780998 |
| 159 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.16195970 |
| 160 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.16187341 |
| 161 | Hepatitis C_Homo sapiens_hsa05160 | 0.15179777 |
| 162 | Prostate cancer_Homo sapiens_hsa05215 | 0.11957081 |

